Cargando…
Risk of herpes zoster reactivation after messenger RNA COVID-19 vaccination: A cohort study
Autores principales: | Birabaharan, Morgan, Kaelber, David C., Karris, Maile Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American Academy of Dermatology, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608757/ https://www.ncbi.nlm.nih.gov/pubmed/34826538 http://dx.doi.org/10.1016/j.jaad.2021.11.025 |
Ejemplares similares
-
Bone Mineral Density Screening Among People With HIV: A Population-Based Analysis in the United States
por: Birabaharan, Morgan, et al.
Publicado: (2021) -
Herpes zoster reactivation after mRNA-1273 (Moderna) SARS-CoV-2 vaccination
por: Channa, Leelakrishna, et al.
Publicado: (2021) -
Herpes zoster ophthalmicus or Herpes zoster maxillaris?
por: Chandravanshi, Shivcharan Lal, et al.
Publicado: (2009) -
SARS-CoV-2 messenger RNA vaccination during herpes zoster infection in an elderly man
por: Katayama, Sho, et al.
Publicado: (2022) -
Cost-Effectiveness of Herpes Zoster Vaccination
por: Sriwijitalai, Won, et al.
Publicado: (2019)